Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol + salbutamol granules in bronchial asthma
CTR20140774Phase 2Active
- Sponsor
- Shaanxi Synthetic Pharmaceutical
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ambroxol + salbutamol in asthma, chronic obstructive pulmonary disease (COPD), sponsored by Shaanxi Synthetic Pharmaceutical. Started Jan 2015; status: active.
02
Drugs
ambroxol + salbutamol
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20140774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140774.